Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,319
Closed -$338K 932
2025
Q4
$338K Sell
1,319
-1,309
-50% -$343K 0.02% 705
2025
Q3
$684K Buy
2,628
+807
+44% +$212K 0.04% 376
2025
Q2
$445K Buy
1,821
+924
+103% +$230K 0.03% 415
2025
Q1
$237K Buy
+897
New +$243K 0.02% 494
2024
Q4
Sell
-1,434
Closed -$454K 583
2024
Q3
$454K Sell
1,434
-75
-5% -$26.7K 0.04% 297
2024
Q2
$564K Buy
1,509
+332
+28% +$112K 0.05% 239
2024
Q1
$408K Sell
1,177
-1,137
-49% -$431K 0.04% 298
2023
Q4
$1.06M Buy
2,314
+1,181
+104% +$582K 0.04% 249
2023
Q3
$551K Buy
+1,133
New +$532K 0.07% 170

Other funds holding HUM

Syon Capital's HUM Position: Q1 2026 in Review

Syon Capital sold out of Humana (HUM) in Q1 2026, closing a stake of 1,319 shares — an estimated $338K sold.

Syon Capital first reported a position in HUM in Q3 2023 and held it in 9 quarters. The position peaked at $1.06M in Q4 2023. 779 funds tracked by Wall St. Rank hold HUM as of Q1 2026.

  • Syon Capital reported no remaining Humana position as of Q1 2026 after selling out during the quarter.
  • Syon Capital sold 1,319 Humana shares in Q1 2026, an estimated $338K.
  • Syon Capital first reported a position in Humana in Q3 2023 and held it in 9 quarters.
  • Syon Capital's Humana position peaked at $1.06M in Q4 2023.
  • 779 funds tracked by Wall St. Rank held Humana as of Q1 2026.

Based on Syon Capital's 13F filing for Q1 2026, filed 13 May 2026.